Ramada Plaza Thraki Hotel,
Alexandroupoli, 10-13/10/2019
IASIS PHARMA participated in the 39th Panhellenic Gastroenterology Conference, organized by the Hellenic Society of Gastroenterology (E.G.E) at Ramada Plaza Thraki Hotel, Alexandroupoli, 10-13 October 2019.
IASIS PHARMA presented Mastihatherapy® caps, the unique traditional herbal medicinal product, containing 350mg of pure Chios Mastic (Pistacia lentiscus var chia), recommended for the treatment of functional dyspepsia.
Physicians showed a strong interest for this herbal medicinal product (E.M.A. 2015), that is known to humanity for over 2500 years. Recently, an analytical method of detection and qualification of the active ingredients of Chios Mastic was developed. Masticadieonmic acid and isomasticadienonic acid were identified.
IASIS PHARMA is the only pharmaceutical company that is supplied with pure Chios Mastic directly from Chios Mastic Growers Association (CMGA), ensuring the quality and originality of Mastihatherapy® caps.
Mastihatherapy® caps are distributed only through pharmacies, in 30 and 90 capsules packages, by Pharma Q, a company of IASIS PHARMA group.
During the conference IASIS PHARMA also presented:
– its key role participation to the establishment of the unique Mastiha Research and Innovation Center (K.E.M), based in Kallimasia, Chios island.
– its new, state-of-the-art Production Facilities, Distribution Center and R&D Center, which are now completed in Koropi.
